Hip Fractures — Epidemiological Study of Floating Hip Injuries in Assiut University Hospitals
Citation(s)
Brioschi M, Randelli F, Capitani P, Capitani D Floating hip in polytraumatized patients: complications, mechanism of injury, and surgical strategy. Int Orthop. 2022 Feb;46(2):361-368. doi: 10.1007/s00264-021-05262-4. Epub 2021 Nov 15. Erratum In: Int Orthop. 2021 Nov 29;:
Burd TA, Hughes MS, Anglen JO The floating hip: complications and outcomes. J Trauma. 2008 Feb;64(2):442-8. doi: 10.1097/TA.0b013e31815eba69.
Meena UK, Bansal MC, Behera P, Goyal D, Kumar R Concomitant ipsilateral acetabular and femoral fractures - an appraisal of outcomes and complications in 34 patients. Acta Orthop Belg. 2021 Sep;87(3):401-410.
Mohamed SO, Ju W, Qin Y, Qi B The term "floating" used in traumatic orthopedics. Medicine (Baltimore). 2019 Feb;98(7):e14497. doi: 10.1097/MD.0000000000014497.
Muller EJ, Siebenrock K, Ekkernkamp A, Ganz R, Muhr G Ipsilateral fractures of the pelvis and the femur--floating hip? A retrospective analysis of 42 cases. Arch Orthop Trauma Surg. 1999;119(3-4):179-82. doi: 10.1007/s004020050385.
Wu CL, Tseng IC, Huang JW, Yu YH, Su CY, Wu CC Unstable pelvic fractures associated with femoral shaft fractures: a retrospective analysis. Biomed J. 2013 Mar-Apr;36(2):77-83. doi: 10.4103/2319-4170.110401.
Yang Y, Zou C, Fang Y, Shakya S Medium-term clinical results in patients with floating hip injuries. BMC Surg. 2023 Feb 20;23(1):40. doi: 10.1186/s12893-023-01927-6.
Zamora-Navas P, Guerado E Vascular complications in floating hip. Hip Int. 2010;20 Suppl 7:S11-8. doi: 10.1177/11207000100200s703. Epub 2010 May 27.
Epidemiological Study of Floating Hip Injuries in Assiut University Hospitals
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
